Skip to content
healthcare.dev

FILKRI

NDC 69448-009, filgrastim-laha, injection, solution, from Accord BioPharma Inc.,.

Product NDC
69448-009
Status
Listed
Labeler
Accord BioPharma Inc.,
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761027
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69448-009 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FILGRASTIM480 ug/.8mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
69448-009-036944800090310 SYRINGE in 1 BOX (69448-009-03) / .8 mL in 1 SYRINGE
69448-009-63694480009631 SYRINGE in 1 BOX (69448-009-63) / .8 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9c2f9573-08fd-43be-a489-8a5e5d8ab2ff

Use it

Look up 69448-009 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69448-009 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69448-009. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.